These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6625375)

  • 1. Early left ventricular dysfunction and chelation therapy in thalassemia major.
    Freeman AP; Giles RW; Berdoukas VA; Walsh WF; Choy D; Murray PC
    Ann Intern Med; 1983 Oct; 99(4):450-4. PubMed ID: 6625375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained normalization of cardiac function by chelation therapy in thalassaemia major.
    Freeman AP; Giles RW; Berdoukas VA; Talley PA; Murray IP
    Clin Lab Haematol; 1989; 11(4):299-307. PubMed ID: 2605872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.
    De Sanctis V; De Sanctis E; Ricchieri P; Gubellini E; Gilli G; Gamberini MR
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():174-80. PubMed ID: 19337174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation.
    Aldouri MA; Wonke B; Hoffbrand AV; Flynn DM; Ward SE; Agnew JE; Hilson AJ
    Acta Haematol; 1990; 84(3):113-7. PubMed ID: 2123060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of deferiprone and deferrioxamine for the treatment of transfusional iron overload in children with beta thalassemia major.
    Waheed N; Ali S; Butt MA
    J Ayub Med Coll Abbottabad; 2014; 26(3):297-300. PubMed ID: 25671931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major.
    Davis BA; O'Sullivan C; Jarritt PH; Porter JB
    Blood; 2004 Jul; 104(1):263-9. PubMed ID: 15001468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to long-term deferoxamine therapy in thalassemia.
    Cohen A; Martin M; Schwartz E
    J Pediatr; 1981 Nov; 99(5):689-94. PubMed ID: 7299539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionuclide assessment of a normal left ventricular response to exercise in patients without evidence of heart disease.
    Schoen HR; Ried C; Arnhold-Schneider M; Sebening H; Sauer E; Bauer R; Pabst HW; Bloemer H
    Eur Heart J; 1986 Feb; 7(2):118-26. PubMed ID: 3699048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous desferrioxamine: the effect of three years' treatment on liver, iron, serum ferritin, and comments on echocardiography.
    Flynn DM; Hoffbrand AV; Politis D
    Birth Defects Orig Artic Ser; 1982; 18(7):347-53. PubMed ID: 6819017
    [No Abstract]   [Full Text] [Related]  

  • 10. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
    Kolnagou A; Yazman D; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):312-22. PubMed ID: 19814677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular function in thalassemia major: protective effect of deferoxamine.
    Desideri A; Scattolin G; Gabellini A; Cavuto F; Vanzelli M; Formichi M; Corbara F
    Can J Cardiol; 1994; 10(1):93-6. PubMed ID: 8111676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deferoxamine improves left ventricular function in beta-thalassemia.
    Grisaru D; Goldfarb AW; Gotsman MS; Rachmilewitz EA; Hasin Y
    Arch Intern Med; 1986 Dec; 146(12):2344-9. PubMed ID: 3778067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in exercise induced left ventricular dysfunction in patients with syndrome X.
    Favaro L; Caplin JL; Fettiche JJ; Dymond DS
    Br Heart J; 1987 Mar; 57(3):232-6. PubMed ID: 3566980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.
    Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Roughton M; Assomull R; Nair SV; Walker JM; Pennell DJ
    Circulation; 2007 Apr; 115(14):1876-84. PubMed ID: 17372174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patients.
    Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):332-8. PubMed ID: 19814679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chelation therapy and ferritin levels in patients with homozygous beta-thalassemia.
    Kattamis C; Lagos P; Langona E
    Prog Clin Biol Res; 1979; 34():351-9. PubMed ID: 531060
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-exercise response of ventricular ejection fraction after total repair of congenital heart disease with left to right shunt.
    Choe KO; Hong YK; Kim MJ; Cho BK
    Yonsei Med J; 1996 Feb; 37(1):19-30. PubMed ID: 8967106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac dysfunction in children with thalassemia major].
    Angelika L; Graf N; Hoffmann W
    Klin Padiatr; 1988; 200(2):102-7. PubMed ID: 3386182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive iron chelation therapy in beta-thalassemia major: some effects on iron metabolism and blood transfusion dependence.
    Silvestroni E; Bianco I; Graziani B; Lerone M; Valente M; Congedo P; Ponzini D; Costantini S
    Acta Haematol; 1982; 68(2):115-23. PubMed ID: 6812366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron chelation in transfusion-dependent thalassemia with chronic hepatitis.
    De Virgiliis S; Cossu P; Sanna G; Frau F; Loi E; Lobrano R; Nucaro A; Toccafondi C; Cornacchia G; Loi A; Cao A
    Acta Haematol; 1982; 67(1):49-56. PubMed ID: 6800202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.